Cancer

Title
Evaluation of Unlicensed Cord Blood Units in Pediatric and Adult Patients
Trial Number
203708081711
Number of Participants
0
Principal Investigator

Patrick Stiff

M.D.
Hematology/Oncology
Coleman Professor of Oncology
Category
Cancer
Eligibility

Participants with FDA-specified indications (see Appendix B for further details):
Hematological malignancies
Certain lysosomal storage and peroxisomal enzyme deficiency disorders
o Hurler syndrome (MPS I)
o Krabbe Disease (Globoid Leukodystrophy)
o X-linked Adrenoleukodystrophy
Primary immunodeficiency diseases
Bone marrow failure
Beta-thalassemia
Signed informed consent (and signed assent, if applicable)
Pediatric and adult patients of any age

Purpose

To provide access to cord blood for those recipients whose best choice for cord blood does not meet all FDA standards but does meet study standards set by the National Marrow Donor Program.
This study will assess how well and how quickly recipientsÂ’ blood counts return to normal after transplant.

Enrollment

(708) 327-2241

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.